![]() |
Ofatumumab (Kesimpta) for RRMS has FDA approval
Yet another drug for RRMS--brand name Kesimpta (ofatumumab)--has received FDA approval according to this article in MarketWatch (August 21, 2020):
Novartis MS drug Kesimpta gets FDA approval - MarketWatch |
All times are GMT -5. The time now is 10:41 AM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.